Showing 1 - 1 results of 1 for search 'Bita Lashtoo-Aghaee', query time: 0.02s
Refine Results
-
1
Two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in major beta-thalassemia patients: A randomized open labeled clinical trial by Mohammadreza Rafati, Hossein Karami, Bita Lashtoo-Aghaee, Bahareh Lashtoo-Aghaee, Mojdeh Dabirian, Razieh Avan
Published 2022-01-01
Article